1. Home
  2. GOSS vs MQT Comparison

GOSS vs MQT Comparison

Compare GOSS & MQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GOSS
  • MQT
  • Stock Information
  • Founded
  • GOSS 2015
  • MQT 1992
  • Country
  • GOSS United States
  • MQT United States
  • Employees
  • GOSS N/A
  • MQT N/A
  • Industry
  • GOSS Biotechnology: Pharmaceutical Preparations
  • MQT Investment Bankers/Brokers/Service
  • Sector
  • GOSS Health Care
  • MQT Finance
  • Exchange
  • GOSS Nasdaq
  • MQT Nasdaq
  • Market Cap
  • GOSS 214.7M
  • MQT 239.7M
  • IPO Year
  • GOSS 2019
  • MQT N/A
  • Fundamental
  • Price
  • GOSS $0.94
  • MQT $10.64
  • Analyst Decision
  • GOSS Strong Buy
  • MQT
  • Analyst Count
  • GOSS 5
  • MQT 0
  • Target Price
  • GOSS $9.20
  • MQT N/A
  • AVG Volume (30 Days)
  • GOSS 943.4K
  • MQT 52.5K
  • Earning Date
  • GOSS 11-07-2024
  • MQT 01-01-0001
  • Dividend Yield
  • GOSS N/A
  • MQT 4.60%
  • EPS Growth
  • GOSS N/A
  • MQT N/A
  • EPS
  • GOSS N/A
  • MQT N/A
  • Revenue
  • GOSS $95,842,000.00
  • MQT N/A
  • Revenue This Year
  • GOSS N/A
  • MQT N/A
  • Revenue Next Year
  • GOSS N/A
  • MQT N/A
  • P/E Ratio
  • GOSS N/A
  • MQT N/A
  • Revenue Growth
  • GOSS N/A
  • MQT N/A
  • 52 Week Low
  • GOSS $0.45
  • MQT $8.59
  • 52 Week High
  • GOSS $1.60
  • MQT $10.67
  • Technical
  • Relative Strength Index (RSI)
  • GOSS 45.42
  • MQT 43.28
  • Support Level
  • GOSS $0.93
  • MQT $10.57
  • Resistance Level
  • GOSS $1.09
  • MQT $10.74
  • Average True Range (ATR)
  • GOSS 0.06
  • MQT 0.08
  • MACD
  • GOSS -0.01
  • MQT -0.03
  • Stochastic Oscillator
  • GOSS 7.37
  • MQT 16.28

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

About MQT Blackrock MuniYield Quality Fund II Inc.

BLACKROCK MUNIYIELD QUALITY FUND II, INC. is a closed-end fund. Its objective is to provide shareholders with as high a level of current income exempt from federal income taxes as is consistent with its investment policies and prudent investment management. It invests in various sectors such as Transportation, Utilities, Health, County/City/Special District/School District, Education, and Housing.

Share on Social Networks: